Vandetanib

Back to search

Molecule Structure

Scientific Name

Vandetanib

Description of the Drug

Vandetanib is an antineoplastic kinase inhibitor used to treat symptomatic or progressive medullary thyroid cancer in patients with unresectable locally advanced or metastatic disease.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB05294

Brand Name(s)

Caprelsa, Zactima

Company Owner(s)

Genzyme Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Ephrin receptor PROTEIN FAMILY INHIBITOR CHEMBL2363043
Tyrosine-protein kinase BRK SINGLE PROTEIN INHIBITOR CHEMBL4601
Vascular endothelial growth factor receptor PROTEIN FAMILY INHIBITOR CHEMBL2095227
Tyrosine-protein kinase receptor RET SINGLE PROTEIN INHIBITOR CHEMBL2041
Tyrosine-protein kinase TIE-2 SINGLE PROTEIN INHIBITOR CHEMBL4128
Tyrosine-protein kinase SRC SINGLE PROTEIN INHIBITOR CHEMBL267
Epidermal growth factor receptor PROTEIN FAMILY INHIBITOR CHEMBL2363049

Unichem Links

SureChEMBL SCHEMBL9044
PharmGKB PA166118341
DrugBank DB05294
PubChem: Thomson Pharma 14761077
PubChem 3081361
Mcule MCULE-4705827953
LINCS LSM-1199
Nikkaji J1.720.281B
PDBe ZD6
BindingDB 21
EPA CompTox Dashboard DTXSID1046681
DrugCentral 4178
Brenda 227978 127382
ChemicalBook CB01011762
Guide to Pharmacology 5717
rxnorm CAPRELSA VANDETANIB
PubChem: Drugs of the Future 12015522
ChEBI 49960
ZINC ZINC000053683345